| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3124430 | British Journal of Oral and Maxillofacial Surgery | 2012 | 4 Pages |
Abstract
Osteoradionecrosis of the jaw remains the most problematic consequence of radiotherapy for the management of head and neck cancer. Treatment is often complex and multimodal. New theories on its pathophysiology have allowed the development of potential treatment modalities, including the use of pentoxifylline and tocopherol. In this retrospective case series we examined the outcomes of patients with ORN prescribed pentoxifylline and tocopherol.
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
N.M.H. Mcleod, C.A. Pratt, T.K. Mellor, P.A. Brennan,